There’s a price war over weight-loss drugs as Wegovy cuts costs for monthly subscribers

Novo Nordisk said game on, as the Denmark-based drugmaker lowered prices on its obesity treatment Wegovy for those without insurance, and said it would deliver the drug to their homes.

The company’s

NVO move comes a week after Eli Lilly & Co. LLY cut prices for its rival weight-loss drug Zepbound.